Evaluation of the in vitro activity of levofloxacin and moxifloxacin tested against Stenotrophomonas maltophilia:: can moxifloxacin activity be predicted by levofloxacin MIC results?

被引：0
|
作者：
Gales, A.
Jones, R.
Janechek, M.
Sader, H.
机构：
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 29卷
关键词：
D O I：
10.1016/S0924-8579(07)71476-0
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
下载
收藏
页码：S461 / S462
页数：2
相关论文
共 50 条
  • [41] Comparative Activity of Moxifloxacin in Vitro Against Obligately Anaerobic Bacteria
    G. Ackermann
    R. Schaumann
    B. Pless
    M. C. Claros
    E. J. C. Goldstein
    A. C. Rodloff
    European Journal of Clinical Microbiology and Infectious Diseases, 2000, 19 : 228 - 232
  • [42] In vitro activity of moxifloxacin and other antimicrobials against respiratory pathogens
    Prado, V
    Giangrieco, M
    Durán, C
    Ojeda, A
    Flaskamp, R
    REVISTA MEDICA DE CHILE, 2000, 128 (12) : 1319 - 1326
  • [43] Comparative activity of moxifloxacin in vitro against obligately anaerobic bacteria
    Ackermann, G
    Schaumann, R
    Pless, B
    Claros, MC
    Goldstein, EJC
    Rodloff, AC
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (03) : 228 - 232
  • [44] In vitro Antimicrobial Activity and Dose Optimization of Eravacycline and Other Tetracycline Derivatives Against Levofloxacin-Non-Susceptible and/or Trimethoprim-Sulfamethoxazole-Resistant Stenotrophomonas maltophilia
    Wu, Jie
    Zhang, Guangcun
    Zhao, Qiang
    Wang, Lifeng
    Yang, Jiyong
    Cui, Junchang
    INFECTION AND DRUG RESISTANCE, 2023, 16 : 6005 - 6015
  • [45] Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae
    Frédénucci, I
    Chomarat, M
    Bercion, R
    Carricajo, A
    Celard, M
    Croizé, J
    Delubac, F
    Fèvre, D
    Fuhrmann, C
    Helfre, M
    Letouzey, MN
    Lelièvre, H
    Mandjee, A
    Marthelet, P
    Meley, R
    Perrier-Gros-Claude, JD
    Ros, A
    Roure, C
    Smati, S
    Thierry, J
    Tous, J
    CLINICAL MICROBIOLOGY AND INFECTION, 2002, 8 (10) : 680 - 683
  • [46] The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci
    Biedenbach, DJ
    Jones, RN
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 25 (01) : 47 - 51
  • [47] In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis
    Akcali, S
    Surucuoglu, S
    Cicek, C
    Ozbakkaloglu, B
    ANNALS OF SAUDI MEDICINE, 2005, 25 (05) : 409 - 412
  • [48] Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia
    Biagi, M.
    Vialichka, A.
    Jurkovic, M.
    Wu, T.
    Shajee, A.
    Lee, M.
    Patel, S.
    Mendes, R. E.
    Wenzler, E.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (09)
  • [49] In vitro activity of levofloxacin against gram-positive bacteria
    Montanari, MP
    Mingoia, M
    Marchetti, F
    Varaldo, PE
    CHEMOTHERAPY, 1999, 45 (06) : 411 - 417
  • [50] Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis
    Qiao, Min
    Ren, Weicong
    Guo, Haiping
    Huo, Fengmin
    Shang, Yuanyuan
    Wang, Yufeng
    Gao, Mengqiu
    Pang, Yu
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 106 : 295 - 299
12345